Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Teresia Wanjiku
Preclinical Assessment of the Interactions Between the Antiretroviral Drugs, Ritonavir and Efavirenz, and the Tyrosine Kinase Inhibitor Erlotinib
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Related publications
Ibrutinib: The First Bruton's Tyrosine Kinase Inhibitor
Prescriber
Pharmacology
Tyrosine Kinase Inhibitor and Target Therapy
Structural and Spectroscopic Study of the Tyrosine Kinase Inhibitor PD-153035
Biophysical Journal
Biophysics
The Fer Tyrosine Kinase Regulates Interactions of Rho GDP-Dissociation Inhibitor a With the Small GTPase Rac
BMC Biochemistry
Biochemistry
Molecular Biology
Pharmacokinetic Interactions Between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz
Infectious Diseases in Obstetrics and Gynecology
Dermatology
Gynecology
Infectious Diseases
Obstetrics
Preclinical Overview of Sorafenib, a Multikinase Inhibitor That Targets Both Raf and VEGF and PDGF Receptor Tyrosine Kinase Signaling
Molecular Cancer Therapeutics
Cancer Research
Oncology
MP470, a Novel Receptor Tyrosine Kinase Inhibitor, in Combination With Erlotinib Inhibits the HER Family/Pi3k/Akt Pathway and Tumor Growth in Prostate Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
‘Covering the Tail’ After Stopping Efavirenz-Based Antiretroviral Therapy
Southern African Journal of HIV Medicine
Infectious Diseases
Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
